| Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma S Labala, PK Mandapalli, A Kurumaddali, VVK Venuganti Molecular pharmaceutics 12 (3), 878-888, 2015 | 90 | 2015 |
| Can pharmacokinetic studies assess the pulmonary fate of dry powder inhaler formulations of fluticasone propionate? G Hochhaus, MJ Chen, A Kurumaddali, U Schilling, Y Jiao, SK Drescher, ... The AAPS journal 23, 1-14, 2021 | 19 | 2021 |
| Optimization of the Transwell® System for Assessing the Dissolution Behavior of Orally Inhaled Drug Products through In Vitro and In Silico Approaches E Amini, A Kurumaddali, S Bhagwat, SM Berger, G Hochhaus Pharmaceutics 13 (8), 1109, 2021 | 10 | 2021 |
| UV spectrophotometric method for irbesartan B Anupama, A Kurumaddali, SN Bhargav, A Surendra Int J Res Pharm and Chem 2 (1), 20-1, 2012 | 8 | 2012 |
| Cascade Impactor Equivalence Testing: Comparison of the Performance of the Modified Chi-Square Ratio Statistic (mCSRS) with the Original CSRS and EMA's Average Bioequivalence … HG Kurumaddali A, Christopher D, Sandell D, Strickland H, Morgan B, Bulitta ... AAPS PharmSciTech 20 (6), 249, 2019 | 7* | 2019 |
| Unraveling the Pulmonary Fate of Fluticasone and Friends: Meeting the Physiologic and Pharmacokinetic Challenges BJB Hochhaus G, Chen M, Shur J, Kurumaddali A, Schilling U, Jiao Y, Drescher ... Respiratory Drug Delivery 1, 139-146, 2020 | 5* | 2020 |
| A meta-analysis of higher-risk myelodysplastic syndrome trials to evaluate the relationship between short-term endpoints and overall survival A Kurumaddali, AH Salem, SK Agarwal Journal of Cancer 10 (22), 5427, 2019 | 3 | 2019 |
| Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics SK Drescher, Y Jiao, MJ Chen, A Kurumaddali, J Shao, E Amini, ... Pharmaceutical research 40 (5), 1177-1191, 2023 | 2 | 2023 |
| Evaluation of the Sensitivity and Robustness of Modified Chi-Square Ratio Statistic for Cascade Impactor Equivalence Testing Through Monte Carlo Simulations A Kurumaddali, D Christopher, H Strickland, B Morgan, C Wiggenhorn, ... AAPS PharmSciTech 21, 1-12, 2020 | 1 | 2020 |
| Acknowledgment to Reviewers of Coatings in 2020 L Abate, M Aleksandrova, S Abdallah, F Aletta, E Abdel-Fattah, H Ali, ... | | 2021 |
| Acknowledgment to Reviewers of Journal of Clinical Medicine in 2020 U Aasa, E Adachi, A Abate, E Adam, A Abbara, M Adamczak, ... J. Clin. Med 10, 865, 2021 | | 2021 |
| ASCPT NEWS HA Intelligence Clinical Pharmacology & Therapeutics 105 (6), 1281, 2019 | | 2019 |
| Abstracts from The Aerosol Society Drug Delivery to the Lungs 29 Edinburgh International Conference Centre Edinburgh, Scotland, UK December 10–12, 2018 JT Pinto, S Radivojev, E Fröhlich, A Paudel, B Lipworth, R Vehring, ... Journal of Aerosol Medicine and Pulmonary Drug Delivery 32 (2), A-1-A-27, 2019 | | 2019 |
| Assessing Central and Peripheral Pulmonary Deposition of Three Fluticasone Propionate (FP) Dry Powder Inhaler (DPI) Formulations with Different Aerodynamic Particle Size … SK Drescher, MJ Chen, A Kurumaddali, U Schilling, Y Jiao, J Shao, ... JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 32 (2), A10-A10, 2019 | | 2019 |
| Pharmacometric Evaluation of In Vitro and In Vivo Methods for Bioequivalence Assessment of Orally Inhaled Drug Products A Kurumaddali University of Florida, 2019 | | 2019 |
| INHALATION PROFILE MODELING FOR FLUTICASONE PROPIONATE DRY POWDER INHALERS IN HEALTHY VOLUNTEERS DURING A FOUR WAY CROSSOVER BIOEQUIVALENCE STUDY. A Kurumaddali, U Schilling, MJ Chen, Y Jiao, B Seay, M Baumstein, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S13-S13, 2018 | | 2018 |
| INHALATION PROFILE MODELING FOR FLUTICASONE PROPIONATE DRY POWDER INHALERS IN HEALTHY VOLUNTEERS DURING A FOUR WAY CROSSOVER BIOEQUIVALENCE STUDY GH A. Kurumaddali, U. Schilling, M.-J. Chen, Y.Jiao, B.Seay, S.M.Baumstein ... American Society for Clinical Pharmacology and Therapeutics https://doi.org …, 2018 | | 2018 |
| Evaluation of the Performance of Modified Chi Square Ratio Statistic for Cascade Impactor Profiles Equivalence Testing A Kurumaddali, L Zhao, D Christopher, B Morgan, D Sandell, H Strickland, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S87-S88, 2016 | | 2016 |
| Evaluation of the Performance of Modified Chi Square Ratio Statistic for Cascade Impactor Profiles Equivalence Testing GH Abhinav Kurumaddali, Li Zhao, David Christopher, Beth Morgan, Dennis ... ACOP7 J Pharmacokinet Pharmacodyn (2016) 43(Suppl 1): 11. https://doi.org/10 …, 2016 | | 2016 |
| Investigation of Pharmacokinetic Sensitivity to Regional Lung Deposition of Locally-Acting Orally Inhaled Drug Products S Boc, DS Conti, MJ Chen, Y Jiao, A Kurumaddali, O Oguntimein, ... | | |
